AETHLON MEDICAL INC | Business Contracts

Executive Employment Agreement, by and between Aethlon Medical, Inc. and Lee Arnold, Ph.D., dated February 1, 2023 (Filed With SEC on February 13, 2023)

Amendment to SBIR Phase II Award Contract, by and among Aethlon Medical, Inc., the National Institutes of Health and the National Cancer Institute, dated October 28, 2020 (Filed With SEC on June 28, 2022)

Lease between Aethlon Medical, Inc. and San Diego Inspire 5, LLC, effective as of October 27, 2021 (Filed With SEC on November 9, 2021)

Amendment No. 2 to Common Stock Sales Agreement, by and between H.C. Wainwright & Co., LLC and Aethlon Medical, Inc., dated March 30, 2020 (Filed With SEC on August 11, 2020)

Form of Indemnification Agreement for Officers and Directors (Filed With SEC on February 11, 2019)

At the Market Offering Agreement, dated March 24, 2022, by and between Aethlon Medical, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on March 24, 2022)

Aethlon Medical, Inc. Amended and Restated Non-Employee Directors Compensation Policy, as modified on February 10, 2022 (Filed With SEC on February 14, 2022)

Amendment to SBIR Phase II Award Contract, effective as of July 1, 2020, by and among Aethlon Medical, Inc., the National Institutes of Health and the National Cancer Institute (Filed With SEC on November 9, 2021)

Aethlon Medical, Inc. Amended and Restated Non-Employee Directors Compensation Policy, as Modified on October 30, 2020 (Filed With SEC on June 24, 2021)

At the Market Offering Agreement, March 22, 2021, by and between Aethlon Medical, Inc. and H.C. Wainwright & CO., LLC (Filed With SEC on March 22, 2021)

Eighth Amendment to Standard Industrial Net Lease, by and between the Company and San Diego Inspire 1, LLC., effective December 7, 2020 (Filed With SEC on February 10, 2021)

Lease, by and between the Company and San Diego Inspire 1, LLC. and San Diego Inspire 2, LLC, effective December 7, 2020 (Filed With SEC on February 10, 2021)

Executive Employment Agreement between the Company and Steven P. LaRosa, MD, dated January 4, 2021 (Filed With SEC on February 10, 2021)

Executive Employment Agreement between the Company and Guy Cipriani, dated January 1, 2021 (Filed With SEC on February 10, 2021)

Employment Agreement between the Company and Dr. Fisher, dated October 30, 2020 (Filed With SEC on November 3, 2020)

Separation Agreement between the Company and Dr. Rodell, dated October 30, 2020 (Filed With SEC on November 3, 2020)

Aethlon Medical, Inc. 2020 Equity Incentive Plan, Form of Restricted Stock Grant, Form of Option Grant and Agreement (Filed With SEC on September 15, 2020)

Aethlon Medical, Inc. Amended and Restated Non-Employee Directors Compensation Policy (Filed With SEC on August 11, 2020)

Description of Aethlon Medical, Inc.s Securities (Filed With SEC on June 25, 2020)

Amended and Restated Executive Employment Agreement for Timothy C. Rodell, M.D., FCCP, dated March 17, 2020, between the Company and Timothy C. Rodell, M.D., FCCP (Filed With SEC on March 23, 2020)

Form of Securities Purchase Agreement, dated January 17, 2020, by and between the Company and the Purchasers (Filed With SEC on January 17, 2020)

Form of Common Stock Purchase Warrant (Filed With SEC on January 17, 2020)

Form of Underwriter Warrant (Filed With SEC on December 11, 2019)

Form of Warrant to Purchase Common Stock (Filed With SEC on December 11, 2019)

Form of Pre-Funded Warrant (Filed With SEC on December 11, 2019)

Form of Underwriting Agreement (Filed With SEC on December 11, 2019)

Assignment Agreement, by and between Aethlon Medical, Inc. and London Health Sciences Center Research Inc., dated November 7, 2006 (Filed With SEC on November 15, 2019)

Form of Underwriter Warrant (Filed With SEC on November 15, 2019)

Form of Pre-Funded Warrant (Filed With SEC on November 15, 2019)

Form of Underwriting Agreement (Filed With SEC on November 15, 2019)

SBIR Phase II Award Contract, effective as of September 12, 2019, by and among Aethlon Medical, Inc., the National Institutes of Health and the National Cancer Institute (Filed With SEC on November 1, 2019)

Seventh Amendment to Standard Industrial Net Lease, dated September 9, 2019, between Aethlon Medical Inc. and San Diego Inspire 1, LLC (Filed With SEC on November 1, 2019)

Strategic Joint Cross-Licensing Agreement, dated June 30, 2019, by and between the Registrant and SeaStar Medical, Inc (Filed With SEC on August 14, 2019)

Amendment No. 1 to Common Stock Sales Agreement, effective as of August 5, 2019, between Aethlon Medical, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on August 12, 2019)

Employment Agreement by and between Aethlon Medical, Inc. and James Frakes dated December 12, 2018 (Filed With SEC on February 11, 2019)

Employment Agreement by and between Aethlon Medical, Inc. and Timothy C. Rodell dated December 10, 2018 (Filed With SEC on February 11, 2019)

Form of Option Grant Agreement for Officers and Directors (Filed With SEC on February 11, 2019)

Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Agreement for Directors (Filed With SEC on February 11, 2019)

Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Agreement for Executives (Filed With SEC on February 11, 2019)

Separation and Consulting Agreement by and between Aethlon Medical, Inc. and James Joyce dated December 10, 2018 (Filed With SEC on February 11, 2019)

AETHLON MEDICAL INC (40)